Andresa Pereira Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andresa Pereira Silva has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Pereira da Silva
Instituto de Medicina Social Universidade do Estado do Rio de Janeiro Rio de Janeiro Brazil
1 shared publication Evonnildo Costa Gonçalves
Universidade Federal do Pará, Brasil
1 shared publication- Jader de Oliveira
Universidade Estadual Paulista (UNESP); Faculdade de Ciências Farmacêuticas; Araraquara; São Paulo; Brazil; Department of Entomology; National Museum of Natural History; Smithsonian Institution; Washington; D.C.; USA
1 shared publication João Lídio da Silva Gonçalves Vianez Júnior
Instituto Evandro Chagas, Brasil
1 shared publicationLohana Marques Leal de Souza
Universidade Federal do Pará, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 54, e00892020
Incidence of viral hepatitis in Brazil from 2009 to 2018: an epidemiological study of confirmed cases of viral hepatitis
Viral hepatitis is a major public health concern. At least 400 million people are chronically infected with HBV and HCV worldwide, and 1.4 million people are infected annually with HAV4. Chronic viral hepatitis, initially silent, takes several years to develop complications. It is believed that 57% of cases of liver cirrhosis and 78% of cases of liver cancer are directly related to HBV and HCV infections5. In highly endemic regions, over 90% of children are infected with HAV at 10 years of age, although few develop complications6. Finally, it is estimated that 1.5 million deaths are related to viral hepatitis.
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 54, e00892020
Open AccessIncidence of viral hepatitis in Brazil from 2009 to 2018: an epidemiological study of confirmed cases of viral hepatitis
Viral hepatitis is a major public health concern. At least 400 million people are chronically infected with HBV and HCV worldwide, and 1.4 million people are infected annually with HAV4. Chronic viral hepatitis, initially silent, takes several years to develop complications. It is believed that 57% of cases of liver cirrhosis and 78% of cases of liver cancer are directly related to HBV and HCV infections5. In highly endemic regions, over 90% of children are infected with HAV at 10 years of age, although few develop complications6. Finally, it is estimated that 1.5 million deaths are related to viral hepatitis.